Finally, a respected University Medical Center, Drexel University College of Medicine, has proven what ILADs physicians have been suggesting for years. The standard testing for Lyme Disease fails to diagnose 60- to 70-percent of patients who are truly affected with Lyme Disease.
For this reason, nearly all of the Lyme Disease patients at Sponaugle Wellness Institute have been infected for years. Because these patients went undiagnosed for so long, they have become “Chronic Lyme Disease” patients, and a majority are suffering from brain infections and therefore have Neurological Lyme Symptoms.*
We’ve summarized the research findings below. Our only disagreement is that the bullseye rash on the skin appears roughly 20 percent of the time, vs. the study’s finding of 60- to 80-percent.*
Drexel University College of Medicine’s Study
Drexel University College of Medicine researchers have found early detection of Lyme Disease can help stop systemic disease involvement, but treatment protocols may not always prevent long-term drawbacks. The study also found that today’s diagnostic tests must be developed further.
In the study, researchers determined patients with Lyme Disease typically develop a rash that appears as a bullseye on the skin (erythema migrans) in 60% to 80% of cases.
The research team also found:
- CDC-recommended ELISA and immunoblot staining may only detect Lyme Disease in 29- to 40-percent of cases;
- Individuals with Lyme Disease may experience symptoms for up to six years in 34 percent of cases, despite following recommended treatment;
- Borrelial spirochetes (which cause Lyme Disease) may comprise up to 25 percent of the organisms in Alzheimer’s patients’ brains;
- The presence of DNA of the Borrelial spirochetes has been confirmed in the synovial tissues of patients with Lyme disease-associated arthritis;
- Skin cultures have a 49 percent sensitivity, while researchers noted polymerase chain-reaction DNA tests for Borrelial and immunoglobulins have variable reliability.
Originally Reported by Helio.com.